These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neurodevelopmental Disorders Associated with PSD-95 and Its Interaction Partners. Levy AM; Gomez-Puertas P; Tümer Z Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457207 [TBL] [Abstract][Full Text] [Related]
4. Truncating variants of the DLG4 gene are responsible for intellectual disability with marfanoid features. Moutton S; Bruel AL; Assoum M; Chevarin M; Sarrazin E; Goizet C; Guerrot AM; Charollais A; Charles P; Heron D; Faudet A; Houcinat N; Vitobello A; Tran-Mau-Them F; Philippe C; Duffourd Y; Thauvin-Robinet C; Faivre L Clin Genet; 2018 Jun; 93(6):1172-1178. PubMed ID: 29460436 [TBL] [Abstract][Full Text] [Related]
5. A deep intronic DLG4 variant resulting in DLG4-related synaptopathy. Levy AM; Ganapathi M; Chung WK; Tümer Z Clin Genet; 2024 Jan; 105(1):77-80. PubMed ID: 37525972 [TBL] [Abstract][Full Text] [Related]
6. BAZ2B haploinsufficiency as a cause of developmental delay, intellectual disability, and autism spectrum disorder. Scott TM; Guo H; Eichler EE; Rosenfeld JA; Pang K; Liu Z; Lalani S; Bi W; Yang Y; Bacino CA; Streff H; Lewis AM; Koenig MK; Thiffault I; Bellomo A; Everman DB; Jones JR; Stevenson RE; Bernier R; Gilissen C; Pfundt R; Hiatt SM; Cooper GM; Holder JL; Scott DA Hum Mutat; 2020 May; 41(5):921-925. PubMed ID: 31999386 [TBL] [Abstract][Full Text] [Related]
7. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. Feyder M; Karlsson RM; Mathur P; Lyman M; Bock R; Momenan R; Munasinghe J; Scattoni ML; Ihne J; Camp M; Graybeal C; Strathdee D; Begg A; Alvarez VA; Kirsch P; Rietschel M; Cichon S; Walter H; Meyer-Lindenberg A; Grant SG; Holmes A Am J Psychiatry; 2010 Dec; 167(12):1508-17. PubMed ID: 20952458 [TBL] [Abstract][Full Text] [Related]
9. Human GRIN2B variants in neurodevelopmental disorders. Hu C; Chen W; Myers SJ; Yuan H; Traynelis SF J Pharmacol Sci; 2016 Oct; 132(2):115-121. PubMed ID: 27818011 [TBL] [Abstract][Full Text] [Related]
10. Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain. Marbach F; Stoyanov G; Erger F; Stratakis CA; Settas N; London E; Rosenfeld JA; Torti E; Haldeman-Englert C; Sklirou E; Kessler E; Ceulemans S; Nelson SF; Martinez-Agosto JA; Palmer CGS; Signer RH; ; Andrews MV; Grange DK; Willaert R; Person R; Telegrafi A; Sievers A; Laugsch M; Theiß S; Cheng Y; Lichtarge O; Katsonis P; Stocco A; Schaaf CP Genet Med; 2021 Aug; 23(8):1465-1473. PubMed ID: 33833410 [TBL] [Abstract][Full Text] [Related]
11. De novo variants in AGO1 recapitulate a heterogeneous neurodevelopmental disorder phenotype. Niu Y; Qian Q; Li J; Gong P; Jiao X; Mao X; Xiao B; Long L; Yang Z Clin Genet; 2022 Apr; 101(4):459-465. PubMed ID: 35060114 [TBL] [Abstract][Full Text] [Related]
12. Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorder. Christensen MB; Levy AM; Mohammadi NA; Niceta M; Kaiyrzhanov R; Dentici ML; Al Alam C; Alesi V; Benoit V; Bhatia KP; Bierhals T; Boßelmann CM; Buratti J; Callewaert B; Ceulemans B; Charles P; De Wachter M; Dehghani M; D'haenens E; Doco-Fenzy M; Geßner M; Gobert C; Guliyeva U; Haack TB; Hammer TB; Heinrich T; Hempel M; Herget T; Hoffmann U; Horvath J; Houlden H; Keren B; Kresge C; Kumps C; Lederer D; Lermine A; Magrinelli F; Maroofian R; Vahidi Mehrjardi MY; Moudi M; Müller AJ; Oostra AJ; Pletcher BA; Ros-Pardo D; Samarasekera S; Tartaglia M; Van Schil K; Vogt J; Wassmer E; Winkelmann J; Zaki MS; Zech M; Lerche H; Radio FC; Gomez-Puertas P; Møller RS; Tümer Z Clin Genet; 2022 Aug; 102(2):98-109. PubMed ID: 35616059 [TBL] [Abstract][Full Text] [Related]
13. Variants in TCF20 in neurodevelopmental disability: description of 27 new patients and review of literature. Torti E; Keren B; Palmer EE; Zhu Z; Afenjar A; Anderson IJ; Andrews MV; Atkinson C; Au M; Berry SA; Bowling KM; Boyle J; Buratti J; Cathey SS; Charles P; Cogne B; Courtin T; Escobar LF; Finley SL; Graham JM; Grange DK; Heron D; Hewson S; Hiatt SM; Hibbs KA; Jayakar P; Kalsner L; Larcher L; Lesca G; Mark PR; Miller K; Nava C; Nizon M; Pai GS; Pappas J; Parsons G; Payne K; Putoux A; Rabin R; Sabatier I; Shinawi M; Shur N; Skinner SA; Valence S; Warren H; Whalen S; Crunk A; Douglas G; Monaghan KG; Person RE; Willaert R; Solomon BD; Juusola J Genet Med; 2019 Sep; 21(9):2036-2042. PubMed ID: 30739909 [TBL] [Abstract][Full Text] [Related]
14. Resequencing and Association Analysis of Six PSD-95-Related Genes as Possible Susceptibility Genes for Schizophrenia and Autism Spectrum Disorders. Xing J; Kimura H; Wang C; Ishizuka K; Kushima I; Arioka Y; Yoshimi A; Nakamura Y; Shiino T; Oya-Ito T; Takasaki Y; Uno Y; Okada T; Iidaka T; Aleksic B; Mori D; Ozaki N Sci Rep; 2016 Jun; 6():27491. PubMed ID: 27271353 [TBL] [Abstract][Full Text] [Related]
16. Heterozygous variants in CTR9, which encodes a major component of the PAF1 complex, are associated with a neurodevelopmental disorder. Meuwissen M; Verstraeten A; Ranza E; Iwaszkiewicz J; Bastiaansen M; Mateiu L; Nemegeer M; Meester JAN; Afenjar A; Amaral M; Ballhausen D; Barnett S; Barth M; Asselbergh B; Spaas K; Heeman B; Bassetti J; Blackburn P; Schaer M; Blanc X; Zoete V; Casas K; Courtin T; Doummar D; Guerry F; Keren B; Pappas J; Rabin R; Begtrup A; Shinawi M; Vulto-van Silfhout AT; Kleefstra T; Wagner M; Ziegler A; Schaefer E; Gerard B; De Bie CI; Holwerda SJB; Abbot MA; Antonarakis SE; Loeys B Genet Med; 2022 Jul; 24(7):1583-1591. PubMed ID: 35499524 [TBL] [Abstract][Full Text] [Related]
17. Clinical and molecular delineation of PUS3-associated neurodevelopmental disorders. Nøstvik M; Kateta SM; Schönewolf-Greulich B; Afenjar A; Barth M; Boschann F; Doummar D; Haack TB; Keren B; Livshits LA; Mei D; Park J; Pisano T; Prouteau C; Umair M; Waqas A; Ziegler A; Guerrini R; Møller RS; Tümer Z Clin Genet; 2021 Nov; 100(5):628-633. PubMed ID: 34415064 [TBL] [Abstract][Full Text] [Related]
18. Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples. Kosmicki JA; Samocha KE; Howrigan DP; Sanders SJ; Slowikowski K; Lek M; Karczewski KJ; Cutler DJ; Devlin B; Roeder K; Buxbaum JD; Neale BM; MacArthur DG; Wall DP; Robinson EB; Daly MJ Nat Genet; 2017 Apr; 49(4):504-510. PubMed ID: 28191890 [TBL] [Abstract][Full Text] [Related]
19. De novo ARHGEF9 missense variants associated with neurodevelopmental disorder in females: expanding the genotypic and phenotypic spectrum of ARHGEF9 disease in females. Scala M; Zonneveld-Huijssoon E; Brienza M; Mecarelli O; van der Hout AH; Zambrelli E; Turner K; Zara F; Peron A; Vignoli A; Striano P Neurogenetics; 2021 Mar; 22(1):87-94. PubMed ID: 32939676 [TBL] [Abstract][Full Text] [Related]
20. ANK3 related neurodevelopmental disorders: expanding the spectrum of heterozygous loss-of-function variants. Kloth K; Lozic B; Tagoe J; Hoffer MJV; Van der Ven A; Thiele H; Altmüller J; Kubisch C; Au PYB; Denecke J; Bijlsma EK; Lessel D Neurogenetics; 2021 Oct; 22(4):263-269. PubMed ID: 34218362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]